Stefanie Ilgenfritz
@stefaniei
Followers
14K
Following
654
Media
639
Statuses
16K
Coverage Chief, Health & Science and Editorial Director, The Future of Everything @ The Wall Street Journal. University of Michigan and NYU alum.
Joined November 2010
They were promised glamorous rehabs in California. They found a much harsher reality. ”I suggest you get a tent.” https://t.co/YAI4z7lRw8 via @WSJ
wsj.com
Operators promise high-end treatment, help addicts sign up for insurance then pile on charges for little in return, say former patients and insurers.
0
1
2
The Justice Department’s criminal healthcare-fraud unit is investigating UnitedHealth Group’s Medicare billing practices https://t.co/7It5aZhwZl via @WSJ
wsj.com
Justice Department prosecutors recently interviewed former employees about company practices that boost federal payments.
6
6
11
The pursuit of longevity can now start before a person is even born. One startup aims to help parents rank embryos based on risks for chronic diseases that affect lifespan. @AmyDMarcus reports for #WSJHealth
https://t.co/05qJxdsoXS via @WSJ
wsj.com
DNA analysis is predicting the likelihood of age-related conditions such as heart disease and cancer.
1
1
2
Thrilled for this recognition of the WSJ team's great Medicare Advantage coverage. Congratulations to all the winners.
Announcing the winners of the 2025 NIHCM #NIHCM Awards in Journalism and Research! See the winners here: https://t.co/wSmgekCpu4
0
0
4
AI may be listening in on your next doctor’s appointment. It’s part of a new technology that’s expanding quickly to hospitals and emergency rooms. The Future of Everything | Health https://t.co/lGNt1fNQS7 via @WSJ
wsj.com
New systems for documenting outpatient visits are adding features and moving into hospitals. “We are just scratching the surface,” one doctor says.
0
1
0
A quarterback, outfielder and fighter pilot all need to track balls and calculate trajectories rapidly. Training such athletes’ eyes can give them an edge, optometrists say. The Future of Everything | Health https://t.co/1H47FNgWZ5 via @WSJ
wsj.com
Sports vision training promises to improve reactions to fast-moving objects.
1
1
2
Electricity has a long history in medicine. Now, new technologies are expanding how electric fields and pulses could treat diseases from rheumatoid arthritis to cancer. The Future of Everything | Health. https://t.co/uuBEOMgsIq via @WSJ
wsj.com
Scientists are using electric fields and pulses to treat the diseases.
5
12
14
An infant with a rare genetic mutation was treated with a gene editing therapy tailored to his specific condition—a breakthrough that could provide a template for others https://t.co/uzG0YM5dpv via @WSJ
wsj.com
The Crispr therapy was tailored to the baby’s specific condition and could provide a template for others.
0
0
2
Americans are living longer than they were 50 or 100 years ago. But chronic diseases are undermining that momentum. https://t.co/G3saMb3HAb via @WSJ
wsj.com
Americans live shorter and less healthy lives than people in other high-income countries.
0
1
2
Women are throwing back more drinks, and raising concerns about the health consequences of their alcohol consumption https://t.co/lZIG2RWyy7 via @WSJ
wsj.com
0
0
1
Got questions about aging and longevity? Join our real-time, written chat with Dr. Eric Topol and WSJ’s health reporters today, Tuesday May 13, from 3-4 p.m. ET https://t.co/7SRgZBY31f via @WSJ
wsj.com
Sort the commenting thread by “Most Liked” to see answers from Dr. Eric Topol and WSJ’s health reporters.
0
0
2
From rare, exotic luxury to hot commodity—how orchids became king of the potted plants. The secret? Cloning. https://t.co/0hvLbhIHeN via @WSJ
wsj.com
Once a rare luxury for the wealthy, orchids can now be had for $10 at the grocery store, thanks to cloning.
0
0
1
“I am taking my own advice,” says Dr. Eric Topol, who follows daily habits he identified in a study of “super agers” who are healthy at ages 85 and above. The Future of Everything | Health looks at his pro tips. https://t.co/t43DhDKs7c via @WSJ
wsj.com
Dr. Eric Topol’s research revealed it’s not so much genes that lead to long life but instead simple and practical steps to stay healthy. He’s taking his own advice.
2
2
4
Scientists sent quantum data a record-breaking 158 miles over an ordinary telecom network in an advance that reduces the cost of ultra-secure quantum communication @AylinWoodward reports for @WSJScience
https://t.co/LyoBJnSzwF via @WSJ
wsj.com
0
1
1
Harvard is fighting back against the Trump administration—and federal funding cuts for research have begun https://t.co/BKiWS83YeM via @WSJ
wsj.com
The university is learning which projects will be hit as the emails arrive.
0
0
1
Are you worried AI could take our jobs? An MIT professor says it doesn’t have to be that way. The Future of Everything | Work https://t.co/WuWrxdscLr via @WSJ
wsj.com
MIT economics professor Sendhil Mullainathan says it is in humans’ power to put artificial intelligence on a path to help us rather than replace us.
0
1
1
Privately run Medicare Advantage plans will get a sizable payment bump from the federal government, thanks to a 5.06% increase announced by the Trump administration Monday https://t.co/UdQfh6DGu2 via @WSJ
wsj.com
Medicare Advantage plans will get a 5.06% rate increase, well above the 2.23% bump that the Biden administration proposed.
0
0
2
In an interview with The Wall Street Journal, Dr. Peter Marks, the FDA’s outgoing vaccine chief, says RFK Jr.’s team wants to show vaccines aren’t safe while weakening rules on unproven treatments https://t.co/W0EkNiPqGW via @WSJ
wsj.com
Dr. Peter Marks says the new health secretary’s team wants to show vaccines aren’t safe while promoting dangerous and unproven treatments.
0
1
1
What's your earliest memory?
Brain scans suggest that babies form memories—even if adults can’t remember them. @NidhiSubs reports for #WSJScienceShorts
https://t.co/WtOHidAUEy via @WSJ
0
0
1
Pharma Stocks Aren't in the Clear, Despite Tariff Exemption—Heard on the Street https://t.co/6rTnUwYtMb via @wsj
wsj.com
Big pharmaceutical stocks mostly rose after President Trump’s executive order exempted medicines from new tariffs. Merck, Bristol-Myers Squibb, and Johnson & Johnson were among t
0
1
1